| abstract |
The present invention provides compounds for use in the treatment, prevention or management of diseases associated with activation, mutation and / or overexpression of one or more kinases, wherein the diseases are associated with Axl overexpression. The disease is also associated with activation, mutation and / or overexpression of one or more other kinases, the compound having the structure of formula (I) The symbols used in formula (I) are as defined herein. |